Search research articles
Contact Us
Filters
Showing results (671-680 of 687) with videos related to
Page
of 69
Sort By:
Lymphology
|
June 16, 2018
Upper Extremity Lymphedema After Axillary Lymph Node Dissection: Prospective Lymphoscintigraphic Evaluation
A Szuba, A Chacaj, M Koba-Wszedybyl, et al.
Immunity
|
September 10, 2013
Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2
Tracy X Cui, Ilona Kryczek, Lili Zhao, et al.
Cancers
|
August 28, 2025
Real Life Evolution of Surgical Approaches in the Management of Endometrial Cancer in Poland
Agnieszka Rychlik, Tomasz Kluz, Grzegorz Szewczyk, et al.
Journal of Neurology
|
April 4, 2025
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab
Lucia Moiola, Alessandra Mandelli, Maciej Tarkowski, et al.
Plant Physiology and Biochemistry : PPB
|
March 24, 2024
PGI1-mediated vascular oxidative pentose phosphate pathway modulates photosynthesis via long-distance cytokinin signaling
Ángela María Sánchez-López, Abdellatif Bahaji, Samuel Gámez-Arcas, et al.
International Journal of Cancer
|
December 15, 2023
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
Davide Dalu, Maciej Tarkowski, Lorenzo Ruggieri, et al.
International Journal of Cancer
|
September 3, 2022
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection
Nicla La Verde, Agostino Riva, Maria Silvia Cona, et al.
Cancer Medicine
|
April 28, 2023
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients
Maria Silvia Cona, Agostino Riva, Davide Dalu, et al.
Cell
|
May 3, 2016
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Weimin Wang, Ilona Kryczek, Lubomír Dostál, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 21, 2009
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
N Mattsson, M Axelsson, S Haghighi, et al.
Page
of 69
Search research articles
Search
Showing results (671-680 of 687) with videos related to
Sort By:
Page
of 69
Lymphology
|
June 16, 2018
Upper Extremity Lymphedema After Axillary Lymph Node Dissection: Prospective Lymphoscintigraphic Evaluation
A Szuba, A Chacaj, M Koba-Wszedybyl, et al.
Immunity
|
September 10, 2013
Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2
Tracy X Cui, Ilona Kryczek, Lili Zhao, et al.
Cancers
|
August 28, 2025
Real Life Evolution of Surgical Approaches in the Management of Endometrial Cancer in Poland
Agnieszka Rychlik, Tomasz Kluz, Grzegorz Szewczyk, et al.
Journal of Neurology
|
April 4, 2025
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab
Lucia Moiola, Alessandra Mandelli, Maciej Tarkowski, et al.
Plant Physiology and Biochemistry : PPB
|
March 24, 2024
PGI1-mediated vascular oxidative pentose phosphate pathway modulates photosynthesis via long-distance cytokinin signaling
Ángela María Sánchez-López, Abdellatif Bahaji, Samuel Gámez-Arcas, et al.
International Journal of Cancer
|
December 15, 2023
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
Davide Dalu, Maciej Tarkowski, Lorenzo Ruggieri, et al.
International Journal of Cancer
|
September 3, 2022
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection
Nicla La Verde, Agostino Riva, Maria Silvia Cona, et al.
Cancer Medicine
|
April 28, 2023
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients
Maria Silvia Cona, Agostino Riva, Davide Dalu, et al.
Cell
|
May 3, 2016
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Weimin Wang, Ilona Kryczek, Lubomír Dostál, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 21, 2009
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
N Mattsson, M Axelsson, S Haghighi, et al.
Page
of 69